Pursuant to Regulation 13(3) of the SEBI (Listing and Obligation and Disclosures requirements) Regulation2015, Kimia Biosciences has informed that it enclosed the statement of investor complaints/grievances for the quarter ended December 31, 2024.
The above information is a part of company’s filings submitted to BSE.